Identification of tyrosine-phosphorylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells

BMC Cancer

Volumn 9, Issue , 2009, Pages 366-

  Li, Haiyu ^a   Ren, Zhenggang ^a   Kang, Xiaonan ^a   Zhang, Lan ^a   Li, Xuefei ^a   Wang, Yan ^a   Xue, Tongchun ^a   Shen, Yuefang ^a   Liu, Yinkun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; JANUS KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTYROSINE; STAT PROTEIN;

ARTICLE; AUTOPHOSPHORYLATION; CANCER CELL CULTURE; CANCER INVASION; CARCINOMA CELL; CELL COMMUNICATION; CELL MIGRATION; CELL MOTILITY; CLUSTER ANALYSIS; ENZYME REGULATION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; MASS SPECTROMETRY; METASTASIS POTENTIAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 70450280616     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-366     Document Type: Article

References (74)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108. 10.3322/canjclin.55.2.74, 15761078.
2. Mareel M, Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 2003, 83(2):337-376.
3. Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet 2007, 8(5):341-352. 10.1038/nrg2101, 17440531.
4. Pawson T, Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science 1997, 278(5346):2075-2080. 10.1126/science.278.5346.2075, 9405336.
5. Steeg PS. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 2003, 3(1):55-63. 10.1038/nrc967, 12509767.
6. Steeg PS. New insights into the tumor metastatic process revealed by gene expression profiling. Am J Pathol 2005, 166(5):1291-1294. 1606385, 15855631.
7. Cairns RA, Khokha R, Hill RP. Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr Mol Med 2003, 3(7):659-671. 10.2174/1566524033479447, 14601640.
8. Baselga J. Targeting tyrosine kinases in cancer: the second wave. Science 2006, 312(5777):1175-1178. 10.1126/science.1125951, 16728632.
9. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001, 411(6835):355-365. 10.1038/35077225, 11357143.
10. Chong PK, Lee H, Kong JW, Loh MC, Wong CH, Lim YP. Phosphoproteomics, oncogenic signaling and cancer research. Proteomics 2008, 8(21):4370-4382. 10.1002/pmic.200800051, 18814326.
11. Wulfkuhle JD, Speer R, Pierobon M, Laird J, Espina V, Deng J, Mammano E, Yang SX, Swain SM, Nitti D. Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. J Proteome Res 2008, 7(4):1508-1517. 10.1021/pr7008127, 18257519.
12. Thomas MB, O'Beirne JP, Furuse J, Chan AT, Abou-Alfa G, Johnson P. Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy. Ann Surg Oncol 2008, 15(4):1008-1014. 10.1245/s10434-007-9705-0, 18236117.
13. Siuti N, Kelleher NL. Decoding protein modifications using top-down mass spectrometry. Nat Methods 2007, 4(10):817-821. 10.1038/nmeth1097, 2365886, 17901871.
14. Domon BAR. Mass Spectrometry and Protein Analysis. Science 2006, 312(5771):212-217. 10.1126/science.1124619, 16614208.
15. Hjerrild M, Gammeltoft S. Phosphoproteomics toolbox: computational biology, protein chemistry and mass spectrometry. FEBS Lett 2006, 580(20):4764-4770. 10.1016/j.febslet.2006.07.068, 16914146.
16. Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue Q, Chen J, Gao DM, Bao WH. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 2001, 7(5):630-636.
17. Takafuji V, Forgues M, Unsworth E, Goldsmith P, Wang XW. An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. Oncogene 2007, 26(44):6361-6371. 10.1038/sj.onc.1210463, 17452979.
18. Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, Lau CK, Li ML, Tam KH, Lam CT, Poon RT. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 2008, 47(3):919-928. 10.1002/hep.22082, 18275073.
19. Sun BS, Dong QZ, Ye QH, Sun HJ, Jia HL, Zhu XQ, Liu DY, Chen J, Xue Q, Zhou HJ. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma. Hepatology 2008, 48(6):1834-1842. 10.1002/hep.22531, 18972404.
20. Guo K, Kang NX, Li Y, Sun L, Gan L, Cui FJ, Gao MD, Liu KY. Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis. BMC Cancer 2009, 9:100. 10.1186/1471-2407-9-100, 2681475, 19331697.
21. Navarro JD, Talreja N, Peri S, Vrushabendra BM, Rashmi BP, Padma N, Surendranath V, Jonnalagadda CK, Kousthub PS, Deshpande N. BioBuilder as a database development and functional annotation platform for proteins. BMC Bioinformatics 2004, 5:43. 10.1186/1471-2105-5-43, 406495, 15099404.
22. Peri S, Navarro JD, Amanchy R, Kristiansen TZ, Jonnalagadda CK, Surendranath V, Niranjan V, Muthusamy B, Gandhi TK, Gronborg M. Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res 2003, 13(10):2363-2371. 10.1101/gr.1680803, 403728, 14525934.
23. Peri S, Navarro JD, Kristiansen TZ, Amanchy R, Surendranath V, Muthusamy B, Gandhi TK, Chandrika KN, Deshpande N, Suresh S. Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res 2004, (32 Database):D497-501. 10.1093/nar/gkh070, 308804, 14681466.
24. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13(11):2498-2504. 10.1101/gr.1239303, 403769, 14597658.
25. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, Christmas R, Avila-Campilo I, Creech M, Gross B. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2007, 2(10):2366-2382. 10.1038/nprot.2007.324, 17947979.
26. Maere S, Heymans K, Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005, 21(16):3448-3449. 10.1093/bioinformatics/bti551, 15972284.
27. Pasder O, Shpungin S, Salem Y, Makovsky A, Vilchick S, Michaeli S, Malovani H, Nir U. Downregulation of Fer induces PP1 activation and cell-cycle arrest in malignant cells. Oncogene 2006, 25(30):4194-4206. 10.1038/sj.onc.1209695, 16732323.
28. Knutson JR, Iida J, Fields GB, McCarthy JB. CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Mol Biol Cell 1996, 7(3):383-396. 275891, 8868467.
29. Martin B, Sanz R, Aragues R, Oliva B, Sierra A. Functional clustering of metastasis proteins describes plastic adaptation resources of breast-cancer cells to new microenvironments. J Proteome Res 2008, 7(8):3242-3253. 10.1021/pr800137w, 18582095.
30. Berger SI, Posner JM, Ma'ayan A. Genes2Networks: connecting lists of gene symbols using mammalian protein interactions databases. BMC Bioinformatics 2007, 8:372. 10.1186/1471-2105-8-372, 2082048, 17916244.
31. Bose R, Molina H, Patterson AS, Bitok JK, Periaswamy B, Bader JS, Pandey A, Cole PA. Phosphoproteomic analysis of Her2/neu signaling and inhibition. Proc Natl Acad Sci USA 2006, 103(26):9773-9778. 10.1073/pnas.0603948103, 1502529, 16785428.
32. Beausoleil SA, Villen J, Gerber SA, Rush J, Gygi SP. A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat Biotechnol 2006, 24(10):1285-1292. 10.1038/nbt1240, 16964243.
33. Madoz-Gurpide J, Canamero M, Sanchez L, Solano J, Alfonso P, Casal JI. A proteomics analysis of cell signaling alterations in colorectal cancer. Mol Cell Proteomics 2007, 6(12):2150-2164. 10.1074/mcp.M700006-MCP200, 17848589.
34. Birzele F, Gewehr JE, Csaba G, Zimmer R. Vorolign--fast structural alignment using Voronoi contacts. Bioinformatics 2007, 23(2):e205-211. 10.1093/bioinformatics/btl294, 17237093.
35. Hatakeyama H, Kondo T, Fujii K, Nakanishi Y, Kato H, Fukuda S, Hirohashi S. Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics 2006, 6(23):6300-6316. 10.1002/pmic.200600488, 17133371.
36. Chen N, Sun W, Deng X, Hao Y, Chen X, Xing B, Jia W, Ma J, Wei H, Zhu Y. Quantitative proteome analysis of HCC cell lines with different metastatic potentials by SILAC. Proteomics 2008, 8(23-24):5108-5118. 10.1002/pmic.200800280, 19016532.
37. Al-Ghoul M, Bruck TB, Lauer-Fields JL, Asirvatham VS, Zapata C, Kerr RG, Fields GB. Comparative proteomic analysis of matched primary and metastatic melanoma cell lines. J Proteome Res 2008, 7(9):4107-4118. 10.1021/pr800174k, 18698805.
38. Ho J, Kong JW, Choong LY, Loh MC, Toy W, Chong PK, Wong CH, Wong CY, Shah N, Lim YP. Novel Breast Cancer Metastasis-Associated Proteins. J Proteome Res 2009, 8(2):583-594. 10.1021/pr8007368, 19086899.
39. Silletti S, Paku S, Raz A. Tumor cell motility and metastasis: Autocrine motility factor as an example of ecto/exoenzyme cytokines. Pathol Oncol Res 1997, 3(3):230-254. 10.1007/BF02899927, 18470736.
40. Simpson CD, Anyiwe K, Schimmer AD. Anoikis resistance and tumor metastasis. Cancer Lett 2008, 272(2):177-185. 10.1016/j.canlet.2008.05.029, 18579285.
41. Townson JL, Naumov GN, Chambers AF. The role of apoptosis in tumor progression and metastasis. Curr Mol Med 2003, 3(7):631-642. 10.2174/1566524033479483, 14601637.
42. Cao L, Han L, Zhang Z, Li J, Qu Z, Du J, Liang X, Liu Y, Liu H, Shi Y. Involvement of anoikis-resistance in the metastasis of hepatoma cells. Exp Cell Res 2009, 315(7):1148-1156. 10.1016/j.yexcr.2008.11.010, 19073174.
43. Abend M, Port M, Schmelz HU, Kraft K, Sparwasser C. Significance of apoptosis in metastasizing testis tumors. Urol Res 2004, 32(1):28-35. 10.1007/s00240-003-0370-x, 14579108.
44. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 1987, 56:881-914. 10.1146/annurev.bi.56.070187.004313, 3039909.
45. Grandal MV, Madshus IH. Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis. J Cell Mol Med 2008, 12(5A):1527-1534. 10.1111/j.1582-4934.2008.00298.x, 18318691.
46. Vallbohmer D, Lenz HJ. Epidermal growth factor receptor as a target for chemotherapy. Clin Colorectal Cancer 2005, 5(Suppl 1):S19-27. 10.3816/CCC.2005.s.003, 15871762.
47. Lee JJ, Chu E. First-line use of anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer. Clin Colorectal Cancer 2007, 6(Suppl 2):S42-46. 10.3816/CCC.2007.s.001, 18021486.
48. Kuwai T, Nakamura T, Sasaki T, Kitadai Y, Kim JS, Langley RR, Fan D, Wang X, Do KA, Kim SJ. Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy. Clin Exp Metastasis 2008, 25(4):477-489. 10.1007/s10585-008-9153-7, 18324358.
49. Hopfner M, Schuppan D, Scherubl H. Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer. World J Gastroenterol 2008, 14(1):1-14. 10.3748/wjg.14.1, 2673371, 18176955.
50. Furuse J. Growth factors as therapeutic targets in HCC. Crit Rev Oncol Hematol 2008, 67(1):8-15. 10.1016/j.critrevonc.2008.02.009, 18434184.
51. Hebenstreit D, Horejs-Hoeck J, Duschl A. JAK/STAT-dependent gene regulation by cytokines. Drug News Perspect 2005, 18(4):243-249. 10.1358/dnp.2005.18.4.908658, 16034480.
52. Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D, Anania FA. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res 2007, 67(6):2497-2507. 10.1158/0008-5472.CAN-06-3075, 17363567.
53. Smirnova OV, Ostroukhova TY, Bogorad RL. JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?. World J Gastroenterol 2007, 13(48):6478-6491. 10.3748/wjg.13.6478, 18161917.
54. Niwa Y, Kanda H, Shikauchi Y, Saiura A, Matsubara K, Kitagawa T, Yamamoto J, Kubo T, Yoshikawa H. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Oncogene 2005, 24(42):6406-6417.
55. Fuke H, Shiraki K, Sugimoto K, Tanaka J, Beppu T, Yoneda K, Yamamoto N, Ito K, Masuya M, Takei Y. Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells. Biochem Biophys Res Commun 2007, 363(3):738-744. 10.1016/j.bbrc.2007.09.049, 17904524.
56. Hickson JA, Huo D, Griend DJ, Lin A, Rinker-Schaeffer CW, Yamada SD. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Res 2006, 66(4):2264-2270. 10.1158/0008-5472.CAN-05-3676, 16489030.
57. Griend DJ, Kocherginsky M, Hickson JA, Stadler WM, Lin A, Rinker-Schaeffer CW. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7. Cancer Res 2005, 65(23):10984-10991. 10.1158/0008-5472.CAN-05-2382, 16322247.
58. Letwin K, Yee SP, Pawson T. Novel protein-tyrosine kinase cDNAs related to fps/fes and eph cloned using anti-phosphotyrosine antibody. Oncogene 1988, 3(6):621-627.
59. Greer P. Closing in on the biological functions of Fps/Fes and Fer. Nat Rev Mol Cell Biol 2002, 3(4):278-289. 10.1038/nrm783, 11994747.
60. Orlovsky K, Theodor L, Malovani H, Chowers Y, Nir U. Gamma interferon down-regulates Fer and induces its association with inactive Stat3 in colon carcinoma cells. Oncogene 2002, 21(32):4997-5001. 10.1038/sj.onc.1205624, 12118379.
61. Piedra J, Miravet S, Castano J, Palmer HG, Heisterkamp N, Garcia de Herreros A, Dunach M. p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction. Mol Cell Biol 2003, 23(7):2287-2297. 10.1128/MCB.23.7.2287-2297.2003, 150740, 12640114.
62. Xu G, Craig AW, Greer P, Miller M, Anastasiadis PZ, Lilien J, Balsamo J. Continuous association of cadherin with beta-catenin requires the non-receptor tyrosine-kinase Fer. J Cell Sci 2004, 117(Pt 15):3207-3219. 10.1242/jcs.01174, 15226396.
63. Reynolds AB, Roczniak-Ferguson A. Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene 2004, 23(48):7947-7956. 10.1038/sj.onc.1208161, 15489912.
64. Davis MA, Ireton RC, Reynolds AB. A core function for p120-catenin in cadherin turnover. J Cell Biol 2003, 163(3):525-534. 10.1083/jcb.200307111, 2173649, 14610055.
65. Anastasiadis PZ, Reynolds AB. Regulation of Rho GTPases by p120-catenin. Curr Opin Cell Biol 2001, 13(5):604-610. 10.1016/S0955-0674(00)00258-1, 11544030.
66. Joshi B, Strugnell SS, Goetz JG, Kojic LD, Cox ME, Griffith OL, Chan SK, Jones SJ, Leung SP, Masoudi H. Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion. Cancer Res 2008, 68(20):8210-8220. 10.1158/0008-5472.CAN-08-0343, 18922892.
67. Miotti S, Tomassetti A, Facetti I, Sanna E, Berno V, Canevari S. Simultaneous expression of caveolin-1 and E-cadherin in ovarian carcinoma cells stabilizes adherens junctions through inhibition of src-related kinases. Am J Pathol 2005, 167(5):1411-1427. 1603782, 16251425.
68. Li H, Leung TC, Hoffman S, Balsamo J, Lilien J. Coordinate regulation of cadherin and integrin function by the chondroitin sulfate proteoglycan neurocan. J Cell Biol 2000, 149(6):1275-1288. 10.1083/jcb.149.6.1275, 2175121, 10851024.
69. Kim L, Wong TW. Growth factor-dependent phosphorylation of the actin-binding protein cortactin is mediated by the cytoplasmic tyrosine kinase FER. J Biol Chem 1998, 273(36):23542-23548. 10.1074/jbc.273.36.23542, 9722593.
70. El Sayegh TY, Arora PD, Laschinger CA, Lee W, Morrison C, Overall CM, Kapus A, McCulloch CA. Cortactin associates with N-cadherin adhesions and mediates intercellular adhesion strengthening in fibroblasts. J Cell Sci 2004, 117(Pt 21):5117-5131. 10.1242/jcs.01385, 15383621.
71. Daly RJ. Cortactin signalling and dynamic actin networks. Biochem J 2004, 382(Pt 1):13-25. 1133910, 15186216.
72. Patel AS, Schechter GL, Wasilenko WJ, Somers KD. Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro. Oncogene 1998, 16(25):3227-3232. 10.1038/sj.onc.1201850, 9681820.
73. Clark ES, Whigham AS, Yarbrough WG, Weaver AM. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res 2007, 67(9):4227-4235. 10.1158/0008-5472.CAN-06-3928, 17483334.
74. Li Y, Tondravi M, Liu J, Smith E, Haudenschild CC, Kaczmarek M, Zhan X. Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res 2001, 61(18):6906-6911.